Levalbuterol is not more cost-effective than albuterol for COPD (multiple letters) [3]

Leslie Hendeles, Abraham Hartzema, Terrance Truitt, James Witko, Michael T. Halpern

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)1176-1178
Number of pages3
Issue number3
StatePublished - Sep 1 2003

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this